Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
134M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
7.59M
-
Shares change
-
+5.01M
-
Total reported value, excl. options
-
$4.97M
-
Value change
-
+$3.32M
-
Number of buys
-
11
-
Number of sells
-
-7
-
Price
-
$0.66
Significant Holders of NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) as of Q4 2024
26 filings reported holding NKGN - NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.59M shares
of 134M outstanding shares and own 5.67% of the company stock.
Largest 10 shareholders include Pathstone Holdings, LLC (2.8M shares), METEORA CAPITAL, LLC (2.77M shares), UNIVERSITY OF CHICAGO (550K shares), Diametric Capital, LP (518K shares), Kepos Capital LP (230K shares), VANGUARD GROUP INC (228K shares), Sequoia Financial Advisors, LLC (156K shares), GEODE CAPITAL MANAGEMENT, LLC (127K shares), ADVISORY RESEARCH INC (43.1K shares), and XTX Topco Ltd (33.6K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.